70 related articles for article (PubMed ID: 26820484)
1. Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma.
Elsnerova K; Mohelnikova-Duchonova B; Cerovska E; Ehrlichova M; Gut I; Rob L; Skapa P; Hruda M; Bartakova A; Bouda J; Vodicka P; Soucek P; Vaclavikova R
Oncol Rep; 2016 Apr; 35(4):2159-70. PubMed ID: 26820484
[TBL] [Abstract][Full Text] [Related]
2. TRAIL-R3-related apoptosis: epigenetic and expression analyses in women with ovarian neoplasia.
Braga Lda C; Alvares da Silva Ramos AP; Traiman P; Silva LM; Lopes da Silva-Filho A
Gynecol Oncol; 2012 Aug; 126(2):268-73. PubMed ID: 22555108
[TBL] [Abstract][Full Text] [Related]
3. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
Yoshihara K; Tajima A; Komata D; Yamamoto T; Kodama S; Fujiwara H; Suzuki M; Onishi Y; Hatae M; Sueyoshi K; Fujiwara H; Kudo Y; Inoue I; Tanaka K
Cancer Sci; 2009 Aug; 100(8):1421-8. PubMed ID: 19486012
[TBL] [Abstract][Full Text] [Related]
5. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
6. Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma.
Taube ET; Denkert C; Sehouli J; Kunze CA; Dietel M; Braicu I; Letsch A; Darb-Esfahani S
Gynecol Oncol; 2016 Mar; 140(3):494-502. PubMed ID: 26721227
[TBL] [Abstract][Full Text] [Related]
7. ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
Ohishi Y; Oda Y; Uchiumi T; Kobayashi H; Hirakawa T; Miyamoto S; Kinukawa N; Nakano H; Kuwano M; Tsuneyoshi M
Clin Cancer Res; 2002 Dec; 8(12):3767-75. PubMed ID: 12473588
[TBL] [Abstract][Full Text] [Related]
8. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
[TBL] [Abstract][Full Text] [Related]
10. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer.
Brennan DJ; Ek S; Doyle E; Drew T; Foley M; Flannelly G; O'Connor DP; Gallagher WM; Kilpinen S; Kallioniemi OP; Jirstrom K; O'Herlihy C; Borrebaeck CA
Eur J Cancer; 2009 May; 45(8):1510-7. PubMed ID: 19272768
[TBL] [Abstract][Full Text] [Related]
12. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
13. Downregulated Salt-inducible Kinase 3 Expression Promotes Chemoresistance in Serous Ovarian Cancer via the ATP-binding Cassette Protein ABCG2.
Liang YL; Wu CH; Kang CY; Lin CN; Shih NY; Lin SH; Chen YC; Hsu KF
J Cancer; 2019; 10(24):6025-6036. PubMed ID: 31762812
[No Abstract] [Full Text] [Related]
14. The role of membrane transporters in ovarian cancer chemoresistance and prognosis.
Cerovska E; Elsnerova K; Vaclavikova R; Soucek P
Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):741-753. PubMed ID: 28511565
[TBL] [Abstract][Full Text] [Related]
15. Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications.
Baczewska M; Supruniuk E; Bojczuk K; Guzik P; Milewska P; Konończuk K; Dobroch J; Chabowski A; Knapp P
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012230
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal Metastasis.
Elsnerova K; Bartakova A; Tihlarik J; Bouda J; Rob L; Skapa P; Hruda M; Gut I; Mohelnikova-Duchonova B; Soucek P; Vaclavikova R
J Cancer; 2017; 8(17):3598-3606. PubMed ID: 29151946
[TBL] [Abstract][Full Text] [Related]
17. A Regulator Role for the ATP-Binding Cassette Subfamily C Member 6 Transporter in HepG2 Cells: Effect on the Dynamics of Cell-Cell and Cell-Matrix Interactions.
Matera I; Miglionico R; Abruzzese V; Marchese G; Ventola GM; Castiglione Morelli MA; Bisaccia F; Ostuni A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003580
[TBL] [Abstract][Full Text] [Related]
18. The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer.
Marjamaa A; Gibbs B; Kotrba C; Masamha CP
Sci Rep; 2023 Oct; 13(1):17476. PubMed ID: 37838788
[TBL] [Abstract][Full Text] [Related]
19. Type IV P-Type ATPases: Recent Updates in Cancer Development, Progression, and Treatment.
Yazlovitskaya EM; Graham TR
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686603
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
